Huons Meditech, the medical device subsidiary of Huons Group, announced that it will showcase its cutting-edge medical devices at the 2025 Korea International Medical & Hospital Equipment Show (KIMES 2025), a major international medical industry exhibition set to begin Thursday at Coex in southern Seoul.

The company will present a diverse range of medical devices, including extracorporeal shockwave, aesthetic, and sterilization/disinfection equipment.

KIMES 2025, running through March 23, is Korea’s largest medical equipment and hospital facility exhibition, featuring over 1,300 companies from around the world and attracting approximately 80,000 medical professionals.

At its exhibition booth, Huons Meditech will introduce the URO-UEMXD and IMPO88 Plus, both utilizing extracorporeal shockwave technology.

The URO-UEMXD, Korea’s first domestically developed product to integrate a shockwave head and an ultrasound probe in an inline system, enables non-invasive diagnosis and treatment of urinary stones using ultrasound imaging.

The IMPO88 Plus, an upgraded model of the IMPO88, is designed to improve erectile dysfunction and alleviate pelvic pain. Clinical trials have shown that the device uniquely reduces inflammation-related cell activity without the need for antibiotics, making it “the only product in Korea” to provide such results, according to the company.

In the aesthetic sector, Huons Meditech will unveil the DermaShine Duo RF, the latest model in its DermaShine series. This new version enhances its precise drug infusion function by incorporating radiofrequency (RF) technology, aligning with global trends. The device is designed to facilitate high-viscosity skin booster injections, drawing interest from dermatology and aesthetic professionals.

During KIMES 2025, Huons Meditech plans to actively engage in business meetings with key hospital officials and medical device buyers from both domestic and international markets. Through these efforts, the company aims to strengthen its foothold in the global market.

Jin Suk Lee, CEO of Huons Meditech, stated, “Our participation in KIMES 2025 serves as an opportunity to showcase Huons Meditech’s advanced technologies on a global stage. We will continue to introduce innovative products and expand our presence in the global medical device industry.”